EndoSonics plans to begin brachytherapy trial:
This article was originally published in Clinica
Executive Summary
EndoSonics, a developer of catheter-based ultrasound systems, has applied to the US FDA for approval to begin a trial of an ultrasound-guided intravascular brachytherapy device. The Rancho Cordova, California-based company has been developing the device, called BRIGADE (beta radiation with IVUS guidance and directed energy), in conjunction with researchers at the Cleveland Clinic Foundation in Ohio. The Phase I trial will be headed by the clinic's Dr Patrick Whitlow. According to EndoSonics, the success of coronary brachytherapy depends on optimal delivery of radiation to the entire vessel wall.